KLEBSIELLA PNEUMONIAE CARBAPENEMASE-PRODUCING KLEBSIELLA PNEUMONIAE IN THE INTENSIVE CARE UNIT: A REAL CHALLENGE TO PHYSICIANS, SCIENTIFIC COMMUNITY, AND SOCIETY

被引：10
作者：
Carvalhaes, Cecilia Godoy [1 ]
Cayo, Rodrigo [1 ]
Gales, Ana Cristina [1 ]
机构：
[1] Univ Fed Sao Paulo, UNIFESP, Lab Alerta, Disciplina Infectol,Dept Med, BR-04039032 Sao Paulo, Brazil
来源：
SHOCK | 2013年 / 39卷 / 07期
关键词：
MDR pathogens; KPC; antimicrobial resistance; fitness cost; mortality; DESORPTION IONIZATION-TIME; HYDROLYZING BETA-LACTAMASE; NEW-YORK; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; PROLONGED-INFUSION; EMERGENCE; OUTBREAK; EPIDEMIOLOGY; ACQUISITION;
D O I：
10.1097/SHK.0b013e31828faf1f
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
The prevalence of multidrug-resistant pathogens, especially in intensive care units, has increased and represents a great concern for medical and scientific community. Infections caused by these pathogens are associated with increased costs, length of hospitalization, and morbidity/mortality rates. The last decade was marked by the spread of carbapenem resistance determinants especially in Enterobacteriaceae isolates. In this review, the Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae is used as an example to discuss the difficulties in dealing with multidrug-resistant pathogens in the intensive care unit setting and how they represent a challenge to the medical-scientific community and, ultimately, the whole society.
引用
收藏
页码：32 / 37
页数：6
相关论文
共 55 条
  • [1] The biological cost of mutational antibiotic resistance: any practical conclusions?
    Andersson, Dan I.
    [J]. CURRENT OPINION IN MICROBIOLOGY, 2006, 9 (05) : 461 - 465
  • [2] Klebsiella pneumoniae Yersiniabactin Promotes Respiratory Tract Infection through Evasion of Lipocalin 2
    Bachman, Michael A.
    Oyler, Jennifer E.
    Burns, Samuel H.
    Caza, Melissa
    Lepine, Francois
    Dozois, Charles M.
    Weiser, Jeffrey N.
    [J]. INFECTION AND IMMUNITY, 2011, 79 (08) : 3309 - 3316
  • [3] Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus
    Besier, S
    Ludwig, A
    Brade, V
    Wichelhaus, TA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) : 1426 - 1431
  • [4] Membrane Efflux and Influx Modulate both Multidrug Resistance and Virulence of Klebsiella pneumoniae in a Caenorhabditis elegans Model
    Bialek, Suzanne
    Lavigne, Jean-Philippe
    Chevalier, Jacqueline
    Marcon, Estelle
    Leflon-Guibout, Veronique
    Davin, Anne
    Moreau, Richard
    Pages, Jean-Marie
    Nicolas-Chanoine, Marie-Helene
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4373 - 4378
  • [5] Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City
    Bradford, PA
    Bratu, S
    Urban, C
    Visalli, M
    Mariano, N
    Landman, D
    Rahal, JJ
    Brooks, S
    Cebular, S
    Quale, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) : 55 - 60
  • [6] Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein
    Bradford, PA
    Urban, C
    Mariano, N
    Projan, SJ
    Rahal, JJ
    Bush, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) : 563 - 569
  • [7] Carbapenems in clinical practice: a guide to their use in serious infection
    Bradley, JS
    Garau, J
    Lode, H
    Rolston, KVI
    Wilson, SE
    Quinn, JP
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 11 (02) : 93 - 100
  • [8] Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York:: Epidemiology and recommendations for detection
    Bratu, S
    Mooty, M
    Nichani, S
    Landman, D
    Gullans, C
    Pettinato, B
    Karumudi, U
    Tolaney, P
    Quale, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 3018 - 3020
  • [9] Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
    Bulik, Catharine C.
    Nicolau, David P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 3002 - 3004
  • [10] In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase-Producing Klebsiella pneumoniae
    Bulik, Catharine C.
    Nicolau, David P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4112 - 4115
123456